
"Exploring the Potential of Psychedelics for Treating Blindness, Stroke, Anorexia, Autism, and Beyond"
Johns Hopkins neuroscientist Gul Dolen's research suggests that psychedelics have the potential to reopen critical periods in the brain, allowing for enhanced learning and adaptation. Experiments with octopuses and mice have shown that psychedelics like MDMA, LSD, and ketamine can reopen critical periods, leading to behavioral changes and improved learning abilities. Dolen is now exploring the use of psychedelics to help stroke patients regain movement and is seeking funding for a phase one safety trial. If successful, this research could have significant implications for treating a variety of health conditions.

